What is Precision Genomics?
Precision Genomics offers personalized cancer treatments by analyzing a patient’s specific genetic makeup.
What is the turnaround time for the ICG100 test?
Once the sample is received in our lab, average turnaround time is 16 days.
Will the patient’s insurance cover the cost of genetic testing?
Yes, most major insurances do.
What equipment do you use?
We use the Illumina MiSeq and NextSeq to sequence.
What sets Intermountain Precision Genomics™ apart from other tests?
Intermountain is on the forefront of personalized cancer testing for all types of genetic mutations. Intermountain Precision Genomics™ is unique in that we offer a Molecular Tumor Board (MTB) review as a part of our service. This team approach gives community oncologists confidence in providing the best options for patients. Drug procurement is available, when requested, and clinical trial information is included in the results.
What is a genetic mutation?
A genetic mutation is an abnormality in a gene, or variant. The ICG100™ tests for SNP's, Small Indels (>20BP), Large Indels (>20BP), and CNV's to identify actionable mutations.
What is an actionable mutation?
An actionable mutation is a gene mutation that has a specific target that can be acted upon by a drug therapy. Not all gene mutations have targets; however, Intermountain Precision Genomics™ has matched many patients with a targeted drug treatment.
Who is eligible for testing?
Precision Genomics’ testing and treatment method is currently being used for patients who have late stage cancer and have failed a traditional treatment method.
What if I don’t live near Intermountain Precision Genomics™?
Intermountain Precision Genomics serves patients within the Intermountain Healthcare system.
What Is ICG100?
Intermountain Precision Genomics™ ICG100™ offers a targeted cancer panel that detects 162 genomic alterations commonly associated with solid tumors. The ICG100™ test examines a larger portion of the patient's DNA (the entire coding region of targeted genes, the exon, rather that a genetic hotspot.
How are tissue samples analyzed?
In order to analyze sequenced nucleotides from the patient’s exome, Intermountain Precision Genomics™ has developed an analytical pipeline that includes a standardized and validated level of mean depth coverage. This required step ensures a qualitative and highly accurate sequence.
What is the cost of genetic testing as compared to other treatments?
The cost is similar depending on the patient, yet the benefits of genetic testing are greater.
Who handles drug procurement?
Intermountain Precision Genomics™ provides oncologists with the option to quickly and conveniently order recommended drug therapies.